Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dasabuvir (Exviera) (1 trial)
ombitasvir (Viekira Pak) (1 trial)
paritaprevir (viekira pak) (1 trial)
ribavirin (virazole) (1 trial)
ritonavir (Norvir) (1 trial)
Hepatitis C (Phase 4)
Trials (1 total)
Trial APIs (5 total)